|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 495/04 | |
| A61K 31/407 |
| (11) | Number of the document | 3271365 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16714004.5 |
| Date of filing the European patent application | 2016-03-15 | |
| (97) | Date of publication of the European application | 2018-01-24 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2016/051465 |
| Date | 2016-03-15 |
| (87) | Number | WO 2016/151432 |
| Date | 2016-09-29 |
| (30) | Number | Date | Country code |
| 201562136223 P | 2015-03-20 | US | |
| 201562138505 P | 2015-03-26 | US |
| (72) |
MADERNA, Andreas, US
SUBRAMANYAM, Chakrapani, US
TUMEY, Lawrence N., US
CHEN, Zecheng, US
CASAVANT, Jeffrey M., US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE |
| BIFUNCTIONAL CYTOTOXIC AGENTS CONTAINING THE CTI PHARMACOPHORE |